Fintel reports that on July 2, 2025, UBS downgraded their outlook for Centene (NYSE:CNC) from Buy to Neutral. Analyst Price Forecast Suggests 36.47% Upside As of June 20, 2025, the average one-year ...

Fintel reports that on July 16, 2025, B of A Securities downgraded their outlook for Centene (NYSE:CNC) from Neutral to ...

Shares of Centene are trading lower on Thursday, hitting a new 52-week low. A rival's profit warning fueled investor anxiety ...

Nearly a week ago, shares of Centene closed down 40.4%, making it the largest single-day drop since the company went public ...

Investing.com - UBS downgraded Centene (NYSE:CNC) stock rating from Buy to Neutral on Wednesday, slashing its price target to $45.00 from $80.00 following the healthcare company’s withdrawal of ...

Investing.com -- Shares of Centene (NYSE:CNC) plunged more than 32% in premarket trading Wednesday after the company pulled its 2025 guidance, citing unexpectedly poor risk adjustment results in ...

Argus downgraded Centene (CNC) to Hold from Buy. Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions ...

Jefferies downgraded Centene to Underperform from Hold with a price target of $52, down ... Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.

Centene’s stock plummets as health insurance giant scraps 2025 financial outlook Enrollees in Centene’s Affordable Care Act plans are a lot sicker than expected Manage alerts for this article ...

At first glance, Centene's balance sheet remains in decent financial shape, especially after the company renegotiated its credit facilities in March, exchanging profit-related covenants for a more ...